David Ansell to Risk Assessment
This is a "connection" page, showing publications David Ansell has written about Risk Assessment.
Connection Strength
0.205
-
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Atherosclerosis. 2018 01; 268:99-107.
Score: 0.122
-
Factors that influence access to the national renal transplant waiting list. Transplantation. 2009 Jul 15; 88(1):96-102.
Score: 0.068
-
Patient dumping. Status, implications, and policy recommendations. JAMA. 1987 Mar 20; 257(11):1500-2.
Score: 0.015